Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It

Authors

Ermias A. Mekonnen
Wondwossen G. Tekle, Valley Baptist Medical Center
Sohum Desai, The University of Texas Rio Grande Valley
Ameer E. Hassan, Valley Baptist Medical Center, University of Texas Rio Grande ValleyFollow

Document Type

Article

Publication Date

2023

Abstract

Intracranial atherosclerotic disease (ICAD) is a common cause of acute ischemic stroke. ICAD has a high rate of recurrent ischemic stroke despite recommended adequate medical treatment. Endovascular treatment of ICAD has been controversial due to high periprocedural complication in historic randomized clinical trials (RCTs). Recently, a multicenter prospective study of stent placement in patients with high grade intracranial stenosis that evaluated safety and efficacy of Balloon-mounted stents (BMS) in symptomatic ICAD showed low rates of periprocedural stroke (5.6%) than the SAMMPRIS (14.7%) and VISSIT (21.4%) trials. This review highlights the recent evolution of endovascular therapy for symptomatic ICAD.

Comments

© The Author(s) 2022

Recommended Citation

Mekonnen, E. A., Tekle, W. G., Desai, S. K., & Hassan, A. E. (2023). Angioplasty and stenting for symptomatic intracranial atherosclerotic disease: how I do it. Interventional Neuroradiology, 29(4), 459-465. https://doi.org/10.1177/15910199221090430

Publication Title

Interventional Neuroradiology

DOI

10.1177/15910199221090430

Academic Level

faculty